| Literature DB >> 29644093 |
Ke Zhang1, Yubo Fan1,2, Nicholas Dunne3, Xiaoming Li1,2,4.
Abstract
Microporosity has a critical role in improving the osteogenesis of scaffolds for bone tissue engineering. Although the exact mechanism, by which it promotes new bone formation, is not well recognized yet, the related hypothesis can be found in many previous studies. This review presents those possible mechanisms about how the microporosity enhances the osteogenic-related functions of cells in vitro and the osteogenic activity of scaffolds in vivo. In summary, the increased specific surface areas by microporosity can offer more protein adsorption sites and accelerate the release of degradation products, which facilitate the interactions between scaffolds and cells. Meanwhile, the unique surface properties of microporous scaffolds have a considerable effect on the protein adsorption. Moreover, capillary force generated by the microporosity can improve the attachment of bone-related cells on the scaffolds surface, and even make the cells achieve penetration into the micropores smaller than them. This review also pays attention to the relationship between the biological and mechanical properties of microporous scaffolds. Although lots of achievements have been obtained, there is still a lot of work to do, some of which has been proposed in the conclusions and perspectives part.Entities:
Keywords: bone tissue engineering; mechanism; microporosity
Year: 2018 PMID: 29644093 PMCID: PMC5887944 DOI: 10.1093/rb/rby001
Source DB: PubMed Journal: Regen Biomater ISSN: 2056-3426
Figure 1.The mechanism diagram of scaffolds with microporosity affects the osteogenic-related cells in vitro
Review the effect of released ions on biological response in vivo/in vitro
| Material composition | Ions released | Role | Biological response | References |
|---|---|---|---|---|
| CaP | Ca | Osteogenesis | Enhance the proliferation and the osteogenic-related factors (bone morphogenic protein-2 (BMP-2), osteocalcin (OCN), osteopontin (OPN), and bone sialoprotein (BSP)) expression of human bone marrow-derived mesenchymal stromal cells (MSC) MEK1/2 is involved in Ca2+ mediated the expression of BMP-2 in human MSC | [ |
| 42SiO2-4P2O5-37.05CaO-15Na2O-1.95SrO | Sr | Osteogenesis Antibacterial | ALP activity, cell number, type I collagen (Col I), and mineral nodule formation of MC3T3-E1 cells are significantly promoted Inhibit the growth of | [ |
| Srx-HA, | Sr | Osteogenesis Cytotoxicity | MG-63 cells attached and proliferated on the Sr10-HA and Sr40-HA surfaces No MG-63 cells are found on the Sr100-HA surface | [ |
| Sr-Ca2ZnSi2O7 | Ca Si Sr Zn | Osteogenesis | Increased the expression of osteogenic markers (Runx-2, OPN, OCN, and BSP) in human bone derived cell (HOB) Induced osteoconductivity in rat tibia defects | [ |
| B-BG: | B Ca Si P | Osteogenesis | ALP activity of BMSC have no obvious difference with different boron contents Enhanced the expression of Col I and Runx-2 of BMSC | [ |
| Lithium-doped CaP | Li | Osteogenesis | Enhance the osteogenesis-related genes (Col I, bone gamma-carboxyglutamate protein (Bglap), osteoprotegerin (OPG), Runx2, β-catenin) expression of MC3T3-E1 Activate the Wnt/β-catenin pathway of MC3T3-E1 Increase new bone formation in rat tibial defects | [ |
| ZnTCP/HA, Zn concentration (0, 0.32, 0.63, 0.88, and 1.26 wt. %) | Zn | Osteogenesis | Zinc concentration between 2.2 and 7.2 μg/ml stimulates osteogenic differentiation in both rat and human BMSC | [ |
| Zinc-doped 45S5 BG | Zn | Cytotoxicity | High Zn ion concentration (122 μM) have cytotoxic effect on MG-63 cells | [ |
| Cobalt BG/collagen | Co | Angiogenesis Osteogenesis | Enhance the expression of VEGF in Human umbilical vein endothelial cells (HUVEC) Upregulated the ALP activity of MC3T3-E1 cell Activates the hypoxia-inducible factor-1α pathway | [ |
| Mg- | Mg Cu | Osteogenesis Angiogenesis Antibacterial | Higher BMP-2, BSP and Col I expression Mg-0.03Cu exhibits the highest expression level of angiogenesis-related genes Mg-Cu alloy declines the number of | [ |
Figure 2.Capillary force in microporous substrate for the cell attachment and penetration. (A) Schematic of cell attachment to the dry and wet microporous substrates, respectively. Dry microporous substrates with capillary force will actively draw in cells and proteins in solution. MP substrate with PBS-filled pores must rely on migration and diffusion for cells and proteins to localize. (B) Fluorescent imaging shows the localization of D1 cells on microporous and non-microporous substrates for the dry and wet (PBS-filled) substrates, respectively. Insert pictures are SEM images of the dry microporous and non-microporous substrates surface with D1 cells. Scale bars = 50 μm [27]
The fabrication technique of the scaffolds with microporosity for bone tissue engineering
| Component | Technique | Pore characteristic | Mechanical properties | Result | References | |
|---|---|---|---|---|---|---|
| 13-93 BG | Robocasting | Multi-scale porosity | The compressive strength (114±24 MPa) within the range of human cortical bone | The surface of scaffolds was fully covered by a HA layer after immersion in SBF for 7 days Cells thoroughly cover the surface of scaffold after 16 days | [ | |
| Porous titanium | Centrifugal granulation technology and stack sintering | Macropores (180.0–341.8 μm) and micropores (6.1–11.8 μm) | The compressive strength of the scaffolds (83.4–108.9 MPa) was high enough for the repair of load-bearing bone defects | Promoted the growth of cells | [ | |
| TCP/alginate | Rapid prototyping | Macro and microporosity | The compressive strength of 60/40 sample around 20 MPa higher than human trabecular bone (0.5–15 MPa) | Allowed cells anchoring and proliferation at scaffold surface | [ | |
| HAP/45S5 bioglass | Polyurethane foam templates | Macropores of 210–1100 μm with microporosity of 1–10 μm | Compressive yield strength (0.8 MPa) close to the upper range of cancellous bone | Cells were successfully seeded on the scaffold surface | [ | |
| Polycaprolactone | Freeze extraction process | Microporosity in the walls of a macropore | Permeability decreases with reduced microporosity | The microporous scaffold has potential used for cartilage regeneration | [ | |
| HA | Directed deposition technique | Micropores size range from 2 to 8 μm | The compressive stiffness of implanted scaffold (1.11±0.8 GPa) was less than that of human trabecular bone | The MP scaffolds contained bone after 8 weeks | [ |